Status:
COMPLETED
Dexmedetomidine Different Doses as Adjuvant to Entropy-assisted General Anesthesia During Functional Endoscopy Sinus Surgery.
Lead Sponsor:
Cairo University
Conditions:
Pain Management
Dexmedetomidine
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
The aim of work to assess the effect of different doses of Dexmedetomidine when used as an adjuvant to entropy-guided general anesthesia on the intraoperative surgical field quality, inhaled anesthesi...
Detailed Description
This randomized comparative study is designed to: * To assess between the effect of different dose Dexmedetomidine infusions on the surgical field quality. * To determine the effect of different dose...
Eligibility Criteria
Inclusion
- American Society of Anesthesiology (ASA) Class I or II undergoing elective functional endoscopic sinus surgery.
Exclusion
- American Society of Anaesthesiology (ASA) Class ≥ III
- Allergy or hypersensitivity to Dexamedetomidine.
- History of myocardial dysfunction.
- Cardiac dysrhythmia and Heart block
- Patients receiving beta blockers or calcium channel blockers
- Patient refusal
- Patient with known history of hepatic or renal disease
Key Trial Info
Start Date :
February 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 2 2022
Estimated Enrollment :
99 Patients enrolled
Trial Details
Trial ID
NCT05226325
Start Date
February 15 2022
End Date
August 2 2022
Last Update
November 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine, Cairo University
Cairo, Egypt